Josh Hall

DNP Doctor of Nursing Practice,  Mayo Clinic - Rochester 

Location: United States

Consulting Services

Biostatistics Legal Support Sales and Marketing

Areas Of Interest

Streptococcal OK432 Diffuse Lymphoma Vaccine, Sabin Electroconvulsive Therapies Therapies, Nondirective Kelch Like ECH Associated Protein 1 Eugeroic Drugs Primary Protein Structure Acer saccharums Etilefrine Leukemia, Lymphocytic, Acute, Mixed Cell Dioxide Snow, Carbon Dislocations, Fracture Empyema, Gallbladder Autoimmune Disease, Neurologic Diffuse Small Cleaved Cell Lymphoma Focused Abdominal Sonography for Trauma Crithidia fasciculata Wasp Venoms Compression Syndromes, Nerve Modern History Composite Resins, Polyacid-Modified Acid Bisdimethylamide, Diazodicarboxylic Employment-Based Services Pancreaticojejunostomy Urologic Surgery, Male Proteins, c-rel Wnt-4 Proteins Cystatin-S5 Learning, Paired-Associate Hydrophilic Contact Lens Proto Oncogene Proteins c ret Alkyl and Aryl Transferases Aged Nutrition Physiology

Professional Narrative

Dr. Josh Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Medical Writer, Mayo Clinic 1994
Executive Director, Harvard Med 2018

Education

Bachelor of science in nursing, Harvard Medical School 2000
Bachelor of science in nursing, Harvard Medical School 2018

Referees

Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02